Potential CAR-T treatment centers announced (England)

Thank you to my NHS England Cancer Pharmacist colleagues for sharing the Information on the ‘potential’ treatment sites for delivery of CAR-T therapy in England.  As yet we are unaware of potential sites in the rest of the home nations, so would be grateful if BOPA members can share any relevant information on this exciting new cancer treatment via our forums or via email to [email protected] so we can share

NHS England is pleased to confirm that the following 8 centres have been selected for the first JACIE inspections for accreditation in delivering Immune Effector Cell therapy, based on their submissions, geographical access and advice from JACIE and industry partners:
 
•         Great Ormond Street Hospital NHS Foundation Trust     
•         King’s College Hospital NHS Foundation Trust     
•         Manchester University Hospitals NHS Foundation Trust (MRI /Royal Manchester Children’s Hospital)     
•         The Christie NHS Foundation Trust
•         The Newcastle Upon Tyne Hospitals NHS Foundation Trust         
•         University College London Hospitals NHS Foundation Trust
•         University Hospitals Birmingham NHS Foundation Trust                
•         University Hospitals Bristol NHS Foundation Trust
 
Further instructions are being sent to the sites identified for inspection.
 
This is the first phase of a national implementation of CAR T cell therapy with further phases expected in due course.
 
 

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article